<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Clin Med Insights Cardiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin Med Insights Cardiol</journal-id>
<journal-id journal-id-type="publisher-id">CIC</journal-id>
<journal-id journal-id-type="hwp">spcic</journal-id>
<journal-title-group>
<journal-title>Clinical Medicine Insights. Cardiology</journal-title>
</journal-title-group>
<issn pub-type="epub">1179-5468</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28469493</article-id>
<article-id pub-id-type="pmc">5392026</article-id>
<article-id pub-id-type="doi">10.1177/1179546817698134</article-id>
<article-id pub-id-type="publisher-id">10.1177_1179546817698134</article-id>
<article-id pub-id-type="publisher-manuscript">CIC-0041395</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Beyond the Electrocardiogram: Mutations in Cardiac Ion Channel Genes Underlie Nonarrhythmic Phenotypes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Roston</surname>
<given-names>Thomas M</given-names>
</name>
<xref ref-type="aff" rid="aff1-1179546817698134">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cunningham</surname>
<given-names>Taylor</given-names>
</name>
<xref ref-type="aff" rid="aff1-1179546817698134">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lehman</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="aff1-1179546817698134">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Laksman</surname>
<given-names>Zachary W</given-names>
</name>
<xref ref-type="aff" rid="aff1-1179546817698134">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krahn</surname>
<given-names>Andrew D</given-names>
</name>
<xref ref-type="aff" rid="aff1-1179546817698134">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanatani</surname>
<given-names>Shubhayan</given-names>
</name>
<xref ref-type="aff" rid="aff1-1179546817698134">1</xref>
<xref ref-type="aff" rid="aff2-1179546817698134">2</xref>
<xref ref-type="corresp" rid="corresp1-1179546817698134"></xref>
</contrib>
</contrib-group>
<aff id="aff1-1179546817698134"><label>1</label>British Columbia Inherited Arrhythmia Program and University of British Columbia, Vancouver, BC, Canada</aff>
<aff id="aff2-1179546817698134"><label>2</label>Children’s Heart Centre, BC Children’s Hospital, Vancouver, BC, Canada</aff>
<author-notes>
<corresp id="corresp1-1179546817698134">Shubhayan Sanatani, Children’s Heart Centre, BC Children’s Hospital, 4480 Oak Street, Vancouver, BC V6H 3V4, Canada. Email: <email>ssanatani@cw.bc.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>11</volume>
<elocation-id>1179546817698134</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>2</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2017</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder content-type="sage">SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">http://www.creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(<ext-link ext-link-type="uri" xlink:href="http://www.uk.sagepub.com/aboutus/openaccess.htm">http://www.uk.sagepub.com/aboutus/openaccess.htm</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Cardiac ion channelopathies are an important cause of sudden death in the young and include long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, idiopathic ventricular fibrillation, and short QT syndrome. Genes that encode ion channels have been implicated in all of these conditions, leading to the widespread implementation of genetic testing for suspected channelopathies. Over the past half-century, researchers have also identified systemic pathologies that extend beyond the arrhythmic phenotype in patients with ion channel gene mutations, including deafness, epilepsy, cardiomyopathy, periodic paralysis, and congenital heart disease. A coexisting phenotype, such as cardiomyopathy, can influence evaluation and management. However, prior to recent molecular advances, our understanding and recognition of these overlapping phenotypes were poor. This review highlights the systemic and structural heart manifestations of the cardiac ion channelopathies, including their phenotypic spectrum and molecular basis.</p>
</abstract>
<kwd-group>
<kwd>Arrhythmia</kwd>
<kwd>ion channel</kwd>
<kwd>genetics</kwd>
<kwd>cardiomyopathy</kwd>
<kwd>sudden unexpected death</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January-December 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="section1-1179546817698134" sec-type="intro">
<title>Introduction</title>
<p>Our understanding of sudden unexpected death (SUD) in the young has improved substantially with the recognition of latent heart disease caused by ion channel gene mutations. The most extensively studied of these is long QT syndrome (LQTS), which was initially described as a lethal, idiopathic disease of severe QT prolongation and deafness.<sup><xref ref-type="bibr" rid="bibr1-1179546817698134">1</xref>,<xref ref-type="bibr" rid="bibr2-1179546817698134">2</xref></sup> In the modern era, registry data and numerous genetic breakthroughs have redefined LQTS as a heritable condition of variable severity.<sup><xref ref-type="bibr" rid="bibr3-1179546817698134">3</xref></sup> To a lesser extent, the other channelopathies, including Brugada syndrome (BrS), catecholaminergic polymorphic ventricular tachycardia (CPVT), idiopathic ventricular fibrillation, early repolarization syndrome, and short QT syndrome (SQTS), have benefited from similar molecular advancements. Some forms of familial atrial fibrillation (AF), sinoatrial node (SAN) dysfunction, sick sinus syndrome (SSS), and progressive cardiac conduction disease (PCCD) also have overlapping features of channelopathy and structural heart disease. When a pathogenic mutation in an ion channel gene is identified in the clinical setting, it can improve risk stratification, family screening and guide treatment.<sup><xref ref-type="bibr" rid="bibr3-1179546817698134">3</xref><xref ref-type="bibr" rid="bibr4-1179546817698134"></xref><xref ref-type="bibr" rid="bibr5-1179546817698134"></xref>–<xref ref-type="bibr" rid="bibr6-1179546817698134">6</xref></sup> In rare cases, an ion channel gene mutation may also manifest as structural heart disease,<sup><xref ref-type="bibr" rid="bibr7-1179546817698134">7</xref><xref ref-type="bibr" rid="bibr8-1179546817698134"></xref><xref ref-type="bibr" rid="bibr9-1179546817698134"></xref><xref ref-type="bibr" rid="bibr10-1179546817698134"></xref><xref ref-type="bibr" rid="bibr11-1179546817698134"></xref>–<xref ref-type="bibr" rid="bibr12-1179546817698134">12</xref></sup> or in noncardiac pathology, such as epilepsy.<sup><xref ref-type="bibr" rid="bibr13-1179546817698134">13</xref><xref ref-type="bibr" rid="bibr14-1179546817698134"></xref>–<xref ref-type="bibr" rid="bibr15-1179546817698134">15</xref></sup> These nonarrhythmic phenotypes can be life-threatening, and electrophysiologists need to be aware of their existence. This review describes the phenotypic spectrum and molecular basis of the nonarrhythmic phenotypes associated with ion channel gene mutations.</p>
</sec>
<sec id="section2-1179546817698134">
<title>Ion Channel Gene Mutations in Cardiomyopathy</title>
<p>Many genes have been implicated in cardiovascular disease, including those associated with arrhythmia and cardiomyopathy. Among these genes, the data supporting pathogenicity are variable, in part because many cases are sporadic, and molecular mechanisms are difficult to elucidate. This section will focus on the genes for which there is reasonable and consistent evidence of a cardiac channelopathy phenotype, in addition to a potential link to cardiomyopathy (<xref ref-type="table" rid="table1-1179546817698134">Table 1</xref>). However, even for the genes meeting this criteria (ie, <italic>SCN5A, KCNQ1, RYR2</italic>, and <italic>HCN4</italic>), disease causation may be questionable. For example, although <italic>SCN5A</italic> has long been associated with BrS, emerging evidence indicates that BrS may be an oligogenic disease (ie, &gt;1 gene influences phenotype).<sup><xref ref-type="bibr" rid="bibr24-1179546817698134">24</xref></sup> Supplementary Table 1 includes the clinical-, genetic-, and population-level evidence for disease causation for each variant. The link between many of these variants and human disease is likely to change as scientific knowledge evolves.</p>
<table-wrap id="table1-1179546817698134" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>Summary of genes implicated in the cardiomyopathy-channelopathy overlap syndrome.</p>
</caption>
<alternatives>
<graphic xlink:href="10.1177_1179546817698134-table1"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="5" rowspan="1">Ion channel genes and their association with channelopathy and cardiomyopathy</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">
<italic>SCN5A</italic>
</th>
<th align="left" colspan="1" rowspan="1">
<italic>KCNQ1</italic>
</th>
<th align="left" colspan="1" rowspan="1">
<italic>RYR2</italic>
</th>
<th align="left" colspan="1" rowspan="1">
<italic>HCN4</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">LVNC</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Nakashima et al<sup><xref ref-type="bibr" rid="bibr16-1179546817698134">16</xref></sup></td>
<td colspan="1" rowspan="1">Ohno et al<sup><xref ref-type="bibr" rid="bibr10-1179546817698134">10</xref></sup>
<break></break>Campbell et al<sup><xref ref-type="bibr" rid="bibr12-1179546817698134">12</xref></sup>
<break></break>Roston et al<sup><xref ref-type="bibr" rid="bibr17-1179546817698134">17</xref></sup></td>
<td colspan="1" rowspan="1">Milano et al<sup><xref ref-type="bibr" rid="bibr18-1179546817698134">18</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">ARVC</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Tiso et al<sup><xref ref-type="bibr" rid="bibr7-1179546817698134">7</xref></sup>
<break></break>Roux-Buisson et al<sup><xref ref-type="bibr" rid="bibr19-1179546817698134">19</xref></sup></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">DCM</td>
<td colspan="1" rowspan="1">McNair et al<sup><xref ref-type="bibr" rid="bibr8-1179546817698134">8</xref>,<xref ref-type="bibr" rid="bibr9-1179546817698134">9</xref></sup>
<break></break>Nair et al<sup><xref ref-type="bibr" rid="bibr20-1179546817698134">20</xref></sup>
<break></break>Gosselin-Badaroudine et al<sup><xref ref-type="bibr" rid="bibr21-1179546817698134">21</xref></sup>
<break></break>Cheng et al<sup><xref ref-type="bibr" rid="bibr22-1179546817698134">22</xref></sup></td>
<td colspan="1" rowspan="1">Xiong et al<sup><xref ref-type="bibr" rid="bibr23-1179546817698134">23</xref></sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="table-fn1-1179546817698134">
<p>Abbreviations: ARVC, arrhythmogenic right ventricular cardiomyopathy; DCM, dilated cardiomyopathy; LVNC, left ventricular noncompaction.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section3-1179546817698134">
<title>SCN5A</title>
<p>Ion influx through the voltage-gated sodium channel (Na<sub>v</sub>1.5) encoded by <italic>SCN5A</italic> is a ubiquitous process underlying cardiomyocyte excitability and cell-to-cell conduction.<sup><xref ref-type="bibr" rid="bibr25-1179546817698134">25</xref></sup>
<italic>SCN5A</italic> has been implicated as a causative or modifier gene in nearly all of the channelopathies, including LQTS, BrS, CPVT, SQTS, AF, PCCD, and SSS.<sup><xref ref-type="bibr" rid="bibr8-1179546817698134">8</xref>,<xref ref-type="bibr" rid="bibr9-1179546817698134">9</xref>,<xref ref-type="bibr" rid="bibr26-1179546817698134">26</xref><xref ref-type="bibr" rid="bibr27-1179546817698134"></xref><xref ref-type="bibr" rid="bibr28-1179546817698134"></xref><xref ref-type="bibr" rid="bibr29-1179546817698134"></xref><xref ref-type="bibr" rid="bibr30-1179546817698134"></xref>–<xref ref-type="bibr" rid="bibr31-1179546817698134">31</xref></sup> The J-wave syndromes, as well as BrS, are linked to loss-of-function mutations in <italic>SCN5A</italic>, whereas LQT3 is associated with gain-of-function mutations.<sup><xref ref-type="bibr" rid="bibr9-1179546817698134">9</xref></sup> In some channelopathies, such as CPVT and SQTS, the <italic>SCN5A</italic> link is limited to single families.<sup><xref ref-type="bibr" rid="bibr26-1179546817698134">26</xref>,<xref ref-type="bibr" rid="bibr28-1179546817698134">28</xref></sup></p>
<p>A well-established nonelectrophysiological manifestation of <italic>SCN5A</italic> variants is dilated cardiomyopathy (DCM).<sup><xref ref-type="bibr" rid="bibr9-1179546817698134">9</xref>,<xref ref-type="bibr" rid="bibr20-1179546817698134">20</xref><xref ref-type="bibr" rid="bibr21-1179546817698134"></xref>–<xref ref-type="bibr" rid="bibr22-1179546817698134">22</xref>,<xref ref-type="bibr" rid="bibr32-1179546817698134">32</xref></sup> Of these, the R222Q variant is supported by the most robust data.<sup><xref ref-type="bibr" rid="bibr9-1179546817698134">9</xref>,<xref ref-type="bibr" rid="bibr20-1179546817698134">20</xref>,<xref ref-type="bibr" rid="bibr22-1179546817698134">22</xref>,<xref ref-type="bibr" rid="bibr32-1179546817698134">32</xref></sup> In a cohort of 338 genotype-elusive patients with DCM, McNair et al<sup><xref ref-type="bibr" rid="bibr9-1179546817698134">9</xref></sup> identified 5 missense <italic>SCN5A</italic> variants in 15 subjects. These individuals experienced arrhythmias seemingly out of proportion to the degree of cardiac dysfunction, including supraventricular arrhythmia, SSS, AF, ventricular tachycardia (VT), and PCCD in the absence of QT prolongation or J-point elevation. These missense variants typically localized to highly conserved regions of <italic>SCN5A</italic>, supporting their pathogenic role, and a shared voltage-sensing mechanism underlying both DCM and arrhythmia.<sup><xref ref-type="bibr" rid="bibr9-1179546817698134">9</xref></sup> R222Q is located in the domain I voltage sensor of <italic>SCN5A</italic> and leads to hyperpolarizing shifts in activation and inactivation gating.<sup><xref ref-type="bibr" rid="bibr22-1179546817698134">22</xref></sup> This mutation reduces peak Na<sup>+</sup> current and incites cardiomyocyte hyperexcitability. An additional modifier in <italic>SCN5A</italic> (H558R) may play a role in this overlap phenotype,<sup><xref ref-type="bibr" rid="bibr22-1179546817698134">22</xref></sup> although DCM has been reported in a second family without H558R polymorphism.<sup><xref ref-type="bibr" rid="bibr20-1179546817698134">20</xref></sup> A distinct, but nearby, mutation (R219H) in <italic>SCN5A</italic> also appears to manifest in AF, VT, and DCM.<sup><xref ref-type="bibr" rid="bibr21-1179546817698134">21</xref></sup> R219H is located in a highly conserved region of <italic>SCN5A</italic> and leads to excessive proton leak, suggesting that acidification of cardiomyocytes may induce DCM.<sup><xref ref-type="bibr" rid="bibr21-1179546817698134">21</xref></sup> Additional unknown genetic modifiers may unmask <italic>SCN5A</italic>-linked DCM, as seen in BrS and LQTS.<sup><xref ref-type="bibr" rid="bibr4-1179546817698134">4</xref>,<xref ref-type="bibr" rid="bibr29-1179546817698134">29</xref></sup> It is believed that causative gene mutations involved in various cardiac phenotypes typically disrupt “final common pathways,” which lead to the disease state.<sup><xref ref-type="bibr" rid="bibr33-1179546817698134">33</xref></sup> The discovery of a <italic>cardiomyopathy-channelopathy overlap syndrome</italic> posed a paradigm shift in electrophysiology, namely, that electrical excitability in Na<sup>+</sup> channels may lead to dilatory remodeling and familial DCM.<sup><xref ref-type="bibr" rid="bibr8-1179546817698134">8</xref></sup></p>
<p>Lenegre-Lev syndrome, also known as PCCD, is defined by gradual idiopathic fibrosis of the cardiac conduction system and is usually seen in the aging population.<sup><xref ref-type="bibr" rid="bibr30-1179546817698134">30</xref></sup> In the past, PCCD was not considered a traditional channelopathy because of its microscopic structural manifestations; however, <italic>SCN5A</italic> mutations have been implicated in PCCD and nonprogressive forms of conduction abnormality.<sup><xref ref-type="bibr" rid="bibr30-1179546817698134">30</xref></sup> The mechanism linking impaired Na<sup>+</sup> current and PCCD is not well established, and aging likely plays a role in unmasking the phenotype.<sup><xref ref-type="bibr" rid="bibr30-1179546817698134">30</xref></sup></p>
<p><italic>SCN5A</italic> variants can be challenging to interpret in the clinical setting. Na<sub>v</sub>1.5 probably has many roles and directly interacts with other proteins, such as <italic>PKP2</italic>-encoded plakophilin, which underlies arrhythmogenic right ventricular cardiomyopathy (ARVC).<sup><xref ref-type="bibr" rid="bibr34-1179546817698134">34</xref></sup> In this setting, loss of <italic>PKP2</italic> function leads to impaired <italic>I</italic><sub>Na</sub>, suggesting an important, shared role between desmosomes, gap junctions, and Na<sup>+</sup> channels in maintaining <italic>I</italic><sub>Na</sub>.<sup><xref ref-type="bibr" rid="bibr35-1179546817698134">35</xref></sup> This discovery is supported by a large BrS cohort with coexisting Na<sup>+</sup> channel dysregulation and <italic>PKP2</italic> variants.<sup><xref ref-type="bibr" rid="bibr36-1179546817698134">36</xref></sup> A growing number of studies also report possible subtle structural changes in patients with BrS<sup><xref ref-type="bibr" rid="bibr34-1179546817698134">34</xref></sup> and abnormal electrograms during epicardial mapping.<sup><xref ref-type="bibr" rid="bibr37-1179546817698134">37</xref></sup> Ablation can normalize the electrocardiogram but does not provide complete protection from arrhythmia.<sup><xref ref-type="bibr" rid="bibr38-1179546817698134">38</xref></sup> This highlights the complex pathophysiological mechanisms of BrS, which remain elusive despite decades of research. Brugada syndrome is likely oligogenic,<sup><xref ref-type="bibr" rid="bibr24-1179546817698134">24</xref></sup> as evidenced in stem cells which did not recapitulate an arrhythmia phenotype in vivo despite harboring <italic>SCN5A</italic> mutations.<sup><xref ref-type="bibr" rid="bibr39-1179546817698134">39</xref></sup> This is highlighted by the relatively high allele frequencies of certain BrS-associated variants (Supplementary Table 1).</p>
</sec>
<sec id="section4-1179546817698134">
<title>KCNQ1</title>
<p><italic>KCNQ1</italic>, encoding the pore-forming subunit (K<sub>v</sub>7.1) of the slowly activating delayed-rectifier potassium channel, underlies LQTS, SQTS,<sup><xref ref-type="bibr" rid="bibr40-1179546817698134">40</xref></sup> and atrial arrhythmias.<sup><xref ref-type="bibr" rid="bibr40-1179546817698134">40</xref>,<xref ref-type="bibr" rid="bibr41-1179546817698134">41</xref></sup> Despite <italic>KCNQ1</italic> being an ion channel gene, cases of LQTS and SQTS complicated by cardiomyopathy have been described.<sup><xref ref-type="bibr" rid="bibr11-1179546817698134">11</xref>,<xref ref-type="bibr" rid="bibr23-1179546817698134">23</xref></sup> One such example is a highly arrhythmogenic cardiomyopathy observed in the setting of a loss-of-function <italic>KCNQ1</italic> (R397Q) mutation.<sup><xref ref-type="bibr" rid="bibr23-1179546817698134">23</xref></sup> A hypothesized mechanism by which a mutation in <italic>KCNQ1</italic> propagates structural heart disease is as follows<sup><xref ref-type="bibr" rid="bibr23-1179546817698134">23</xref></sup>: <italic>KCNQ1</italic> and <italic>KCNE1</italic> form repolarizing channels which are regulated by beta-adrenergic-mediated protein kinase A–dependent phosphorylation. <italic>IK</italic><sub>s</sub> currents are also sensitive to Ca<sup>2+</sup>, in part through interaction with calmodulin. Abnormal interaction between mutant K<sub>v</sub>7.1 and calmodulin may lead to Ca<sup>2+</sup> dysregulation and impaired cardiomyocyte contractility, thus producing a structural phenotype. Similar mechanisms have been theorized in other cardiomyopathy-channelopathy overlap syndromes,<sup><xref ref-type="bibr" rid="bibr9-1179546817698134">9</xref>,<xref ref-type="bibr" rid="bibr42-1179546817698134">42</xref>,<xref ref-type="bibr" rid="bibr43-1179546817698134">43</xref></sup> including <italic>SCN5A</italic>-associated DCM and left ventricular noncompaction (LVNC) and <italic>KCNQ1-</italic>associated DCM in 3 patients with SQTS.<sup><xref ref-type="bibr" rid="bibr44-1179546817698134">44</xref></sup> However, incomplete phenotyping and so-called tachycardia-induced cardiomyopathy may confound these reports, and mechanistic descriptions are largely speculative. Alternatively, <italic>KCNQ1</italic> may be a genetic modifier of structural heart disease. These dramatic but isolated observations highlight the need for further biophysical and linkage studies and detailed phenotyping.</p>
<p>An overlap between a channelopathy and a developmental abnormality has recently been seen in the form of LVNC.<sup><xref ref-type="bibr" rid="bibr16-1179546817698134">16</xref>,<xref ref-type="bibr" rid="bibr42-1179546817698134">42</xref>,<xref ref-type="bibr" rid="bibr45-1179546817698134">45</xref></sup> Left ventricular noncompaction is an uncommon congenital cardiomyopathy defined by intertrabecular sinusoids communicating with the ventricular cavity. In 2013, Nakashima reported LVNC in a young child with cardiac arrest, QTc prolongation, and a pathogenic <italic>KCNQ1</italic> variant.<sup><xref ref-type="bibr" rid="bibr16-1179546817698134">16</xref></sup> Accordingly, ion channel genes have embryological roles<sup><xref ref-type="bibr" rid="bibr46-1179546817698134">46</xref></sup> and may also be downstream targets of transcription factors. These provide hypothetical mechanisms by which <italic>KCNQ1</italic> may relate to congenital heart disease. However, the channelopathy-LVNC link is ill-defined and may be attributable to the coexistence of 2 rare, unrelated pathologies.</p>
</sec>
<sec id="section5-1179546817698134">
<title>RYR2</title>
<p>Catecholaminergic polymorphic ventricular tachycardia is a channelopathy that leads to polymorphic VT during exertion or emotional stress. Priori et al<sup><xref ref-type="bibr" rid="bibr47-1179546817698134">47</xref></sup> implicated <italic>RYR2</italic> in CPVT, which encodes the ryanodine receptor 2 (RyR2).<sup><xref ref-type="bibr" rid="bibr47-1179546817698134">47</xref></sup> Ryanodine receptor 2 is the largest ion channel in the human genome with a complex heterotetrameric structure, which allows it to interact with the cytosol, plasma membrane, and lumen of the sarcoplasmic reticulum.<sup><xref ref-type="bibr" rid="bibr48-1179546817698134">48</xref></sup> As such, RyR2 may be involved in cellular processes that extend beyond the action potential. Since 2001, more than 200 gain-of-function <italic>RYR2</italic> variants have been described.<sup><xref ref-type="bibr" rid="bibr49-1179546817698134">49</xref></sup> To a lesser extent, loss-of-function <italic>RYR2</italic> mutations exist, but instead underlie an arrhythmia syndrome distinct from CPVT.<sup><xref ref-type="bibr" rid="bibr50-1179546817698134">50</xref><xref ref-type="bibr" rid="bibr51-1179546817698134"></xref>–<xref ref-type="bibr" rid="bibr52-1179546817698134">52</xref></sup>
<italic>RYR2</italic> variants<sup><xref ref-type="bibr" rid="bibr7-1179546817698134">7</xref>,<xref ref-type="bibr" rid="bibr10-1179546817698134">10</xref>,<xref ref-type="bibr" rid="bibr17-1179546817698134">17</xref>,<xref ref-type="bibr" rid="bibr19-1179546817698134">19</xref></sup> and abnormalities in Ca<sup>2+</sup> current<sup><xref ref-type="bibr" rid="bibr53-1179546817698134">53</xref></sup> are also associated with changes in cardiac structure.</p>
<p>Arrhythmogenic right ventricular cardiomyopathy came to be recognized due to its severe electrophysiological consequences (and extracardiac cutaneous phenotype). Accordingly, diagnostic criteria rely on electrical findings,<sup><xref ref-type="bibr" rid="bibr54-1179546817698134">54</xref></sup> in addition to coexistent fibrofatty ventricular infiltration, making it the prototypical cardiomyopathy-channelopathy overlap syndrome. Arrhythmogenic right ventricular cardiomyopathy is a disorder of the intercalated disk, desmosome, and gap junction,<sup><xref ref-type="bibr" rid="bibr55-1179546817698134">55</xref>,<xref ref-type="bibr" rid="bibr56-1179546817698134">56</xref></sup> of which the intercalated disk is integral in forming the myocardial scaffold.<sup><xref ref-type="bibr" rid="bibr56-1179546817698134">56</xref></sup> The intercalated disk interacts with a variety of proteins, including ion channels.<sup><xref ref-type="bibr" rid="bibr57-1179546817698134">57</xref></sup> As Priori and colleagues were describing <italic>RYR2</italic>-associated CPVT, Tiso et al<sup><xref ref-type="bibr" rid="bibr7-1179546817698134">7</xref></sup> published on 4 ARVC families with variants in <italic>RYR2</italic>. More recently, 6 rare missense variants in <italic>RYR2</italic> were identified in 64 previously genotype-elusive ARVC subjects.<sup><xref ref-type="bibr" rid="bibr19-1179546817698134">19</xref></sup> Tiso and colleagues hypothesized that Ca<sup>2+</sup> dysregulation at the sarcoplasmic reticulum, a mechanism also proposed to underlie CPVT, leads to myocardial necrosis, resulting in ARVC.<sup><xref ref-type="bibr" rid="bibr7-1179546817698134">7</xref></sup> The role of the intercalated disk in this relationship is unclear, and data linking ion channels to the intercalated disk involve Na<sup>+</sup> rather than Ca<sup>2+</sup> current.<sup><xref ref-type="bibr" rid="bibr57-1179546817698134">57</xref></sup> Further molecular work is needed to determine the mechanism of <italic>RYR2-</italic>related ARVC.</p>
<p><italic>RYR2</italic> is also linked to LVNC.<sup><xref ref-type="bibr" rid="bibr10-1179546817698134">10</xref>,<xref ref-type="bibr" rid="bibr45-1179546817698134">45</xref></sup> Our group recently described a loss-of-function mutation in a family with LVNC and atypical CPVT.<sup><xref ref-type="bibr" rid="bibr17-1179546817698134">17</xref></sup> In another family, there are 2 female CPVT probands with deletion of exon 3 in <italic>RYR2</italic>, exercise-induced ventricular ectopy, and LVNC.<sup><xref ref-type="bibr" rid="bibr10-1179546817698134">10</xref></sup> Family screening identified 8 mutation carriers, of which 7 had LVNC. A structural phenotype related to <italic>RYR2</italic> exon 3 deletion has also been described in an unrelated patient.<sup><xref ref-type="bibr" rid="bibr12-1179546817698134">12</xref></sup> These are some of the reports describing large exon deletions of RyR2. At present, it is not known whether larger deletions of RyR2 are likely to manifest in structural heart disease. In addition, some <italic>RYR2</italic> mutations may actually be benign polymorphisms,<sup><xref ref-type="bibr" rid="bibr58-1179546817698134">58</xref></sup> and variants of unknown significance in <italic>RYR2</italic> are common,<sup><xref ref-type="bibr" rid="bibr59-1179546817698134">59</xref></sup> making it difficult to link rare structural phenotypes to <italic>RYR2</italic>.</p>
</sec>
<sec id="section6-1179546817698134">
<title>HCN4</title>
<p>Before the genetic basis of conduction disease was known, SAN dysfunction was thought to be a channelopathy, caused by impaired “funny current,” <italic>I</italic><sub>f</sub>.<sup><xref ref-type="bibr" rid="bibr60-1179546817698134">60</xref></sup> Using a candidate gene approach, Macri et al<sup><xref ref-type="bibr" rid="bibr61-1179546817698134">61</xref></sup> demonstrated that <italic>HCN4</italic> variants cause chronotropic incompetence. <italic>HCN4</italic> is expressed in the SAN and encodes the hyperpolarization-activated cyclic nucleotide–gated potassium channel 4. Since their work, <italic>HCN4</italic> has been implicated in familial sinus bradycardia,<sup><xref ref-type="bibr" rid="bibr18-1179546817698134">18</xref>,<xref ref-type="bibr" rid="bibr62-1179546817698134">62</xref></sup> tachycardia-bradycardia syndrome, and AF.<sup><xref ref-type="bibr" rid="bibr62-1179546817698134">62</xref></sup> Unlike traditional channelopathies, <italic>HCN4</italic> does not appear to manifest in primary ventricular arrhythmia.</p>
<p>In 2014, Milano and colleagues<sup><xref ref-type="bibr" rid="bibr18-1179546817698134">18</xref></sup> showed that <italic>HCN4</italic> may have a structural role in a family with SAN dysfunction, LVNC, and <italic>HCN4</italic> mutation. There are two main mechanistic hypotheses to explain HCN4-related LVNC. The first is that although <italic>HCN4</italic> is expressed predominantly in the SAN, it is coexpressed in ventricular progenitor cells.<sup><xref ref-type="bibr" rid="bibr63-1179546817698134">63</xref></sup> Under these circumstances, <italic>HCN4</italic> mutations could lead to congenital heart disease and then later manifest as bradycardia after birth. The second hypothesis is that trabeculation is a compensatory response to bradycardia, as seen in athletes with low resting heart rates.<sup><xref ref-type="bibr" rid="bibr64-1179546817698134">64</xref></sup> Most recently, multiple variants in <italic>HCN4</italic>, including those previously implicated in LVNC,<sup><xref ref-type="bibr" rid="bibr18-1179546817698134">18</xref>,<xref ref-type="bibr" rid="bibr65-1179546817698134">65</xref></sup> have been shown to underlie ascending aortic dilation.<sup><xref ref-type="bibr" rid="bibr66-1179546817698134">66</xref></sup> Young patients with symptomatic, chronotropic incompetence, LVNC, and/or aortic dilation should be considered for sequencing of <italic>HCN4</italic>.</p>
</sec>
</sec>
<sec id="section7-1179546817698134">
<title>Extracardiac Manifestations of Ion Channel Gene Mutations</title>
<p>The following section discusses the channelopathies which have been classically associated with a systemic phenotype, as well as emerging theories supporting the systemic impact of these mutations. For these syndromes, a description of the systemic findings often predated the causative molecular abnormality. <xref ref-type="table" rid="table2-1179546817698134">Table 2</xref> summarizes these genotype-phenotype correlations.</p>
<table-wrap id="table2-1179546817698134" orientation="portrait" position="float">
<label>Table 2.</label>
<caption>
<p>Summary of genes implicated in systemic syndromes.</p>
</caption>
<alternatives>
<graphic xlink:href="10.1177_1179546817698134-table2"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Syndrome</th>
<th align="left" colspan="1" rowspan="1">Gene</th>
<th align="left" colspan="1" rowspan="1">Functional significance</th>
<th align="left" colspan="1" rowspan="1">Manifestations</th>
<th align="left" colspan="1" rowspan="1">Citation</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">Jervell and Lange-Nielsen syndrome</td>
<td colspan="1" rowspan="1"><italic>KCNQ1</italic>/<italic>KCNE1</italic></td>
<td colspan="1" rowspan="1">LoF</td>
<td colspan="1" rowspan="1">QTc prolongation<break></break>Deafness</td>
<td colspan="1" rowspan="1">Neyround et al<sup><xref ref-type="bibr" rid="bibr1-1179546817698134">1</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Timothy syndrome</td>
<td colspan="1" rowspan="1">
<italic>CACNA1c</italic>
</td>
<td colspan="1" rowspan="1">GoF</td>
<td colspan="1" rowspan="1">QTc prolongation<break></break>Congenital heart disease<break></break>Syndactyly<break></break>Autism<break></break>Immunodeficiency<break></break>Seizures/neurological deficits<break></break>Hypotonia<break></break>Electrolyte derangements<break></break>Hypoglycemia</td>
<td colspan="1" rowspan="1">Splawski et al<sup><xref ref-type="bibr" rid="bibr67-1179546817698134">67</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Andersen-Tawil syndrome</td>
<td colspan="1" rowspan="1">
<italic>KCNJ2</italic>
</td>
<td colspan="1" rowspan="1">LoF</td>
<td colspan="1" rowspan="1">QTc prolongation<break></break>Micrognathia<break></break>Hypertelorism<break></break>Short stature<break></break>Scoliosis<break></break>Low-set ears<break></break>Clinodactyly<break></break>Periodic paralysis</td>
<td colspan="1" rowspan="1">Plaster et al<sup><xref ref-type="bibr" rid="bibr68-1179546817698134">68</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Primary epilepsy</td>
<td colspan="1" rowspan="1">
<italic>KCNH2</italic>
<break></break>
<italic>KCNQ1</italic>
<break></break>
<italic>RYR2</italic>
<break></break>
<italic>KCNJ2</italic>
<break></break>
<italic>SCN5A</italic>
</td>
<td colspan="1" rowspan="1">LoF<break></break>LoF<break></break>Not listed<break></break>LoF<break></break>LoF</td>
<td colspan="1" rowspan="1">LQT2<break></break>LQT1<break></break>CPVT<break></break>ATS (LQT7)<break></break>BrS</td>
<td colspan="1" rowspan="1">Johnson et al<sup><xref ref-type="bibr" rid="bibr13-1179546817698134">13</xref></sup>
<break></break>Zamorano-Leon et al<sup><xref ref-type="bibr" rid="bibr14-1179546817698134">14</xref></sup>
<break></break>Goldman et al<sup><xref ref-type="bibr" rid="bibr69-1179546817698134">69</xref></sup>
<break></break>Nagrani et al<sup><xref ref-type="bibr" rid="bibr70-1179546817698134">70</xref></sup>
<break></break>Marquez et al<sup><xref ref-type="bibr" rid="bibr71-1179546817698134">71</xref></sup>
<break></break>Sandorfi et al<sup><xref ref-type="bibr" rid="bibr72-1179546817698134">72</xref></sup></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="table-fn2-1179546817698134">
<p>Abbreviations: ATS/LQT7, Andersen-Tawil syndrome/long QT syndrome type 7; BrS, Brugada syndrome; CPVT, catecholaminergic polymorphic ventricular tachycardia; GoF, gain of function; LoF, loss of function; LQT1, long QT syndrome type 1; LQT2, long QT syndrome type 2.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section8-1179546817698134">
<title>Syndromic features of the long QT syndrome</title>
<p>The Jervell and Lange-Nielsen syndrome was described over 50 years ago as a constellation of congenital deafness, childhood SUD, and QTc prolongation.<sup><xref ref-type="bibr" rid="bibr1-1179546817698134">1</xref>,<xref ref-type="bibr" rid="bibr2-1179546817698134">2</xref>,<xref ref-type="bibr" rid="bibr73-1179546817698134">73</xref></sup> We now know that this syndrome is caused by homozygous recessive mutations in <italic>KCNE</italic> and <italic>KCNQ1</italic>.<sup><xref ref-type="bibr" rid="bibr1-1179546817698134">1</xref></sup> In the heterozygous state, enough K<sup>+</sup> is secreted into the endolymph to maintain the endocochlear potentials responsible for sensory conduction.<sup><xref ref-type="bibr" rid="bibr74-1179546817698134">74</xref></sup> However, in a homozygous state, little or no functional protein is produced, resulting in deafness and a markedly prolonged QT interval.<sup><xref ref-type="bibr" rid="bibr1-1179546817698134">1</xref>,<xref ref-type="bibr" rid="bibr73-1179546817698134">73</xref>,<xref ref-type="bibr" rid="bibr75-1179546817698134">75</xref></sup></p>
<p>Timothy syndrome (TS) (allelic to LQT8) is an autosomal dominant type of LQTS, characterized by congenital heart disease, syndactyly, autism, and immunodeficiency.<sup><xref ref-type="bibr" rid="bibr67-1179546817698134">67</xref>,<xref ref-type="bibr" rid="bibr76-1179546817698134">76</xref>,<xref ref-type="bibr" rid="bibr77-1179546817698134">77</xref></sup> Timothy syndrome is almost universally lethal by the third decade of life.<sup><xref ref-type="bibr" rid="bibr67-1179546817698134">67</xref></sup> In 1995, the Ca<sub>v</sub>1.2 Ca<sup>2+</sup> channel encoded by <italic>CACNA1c</italic>, usually in exon 8A, was found to be causative in TS.<sup><xref ref-type="bibr" rid="bibr67-1179546817698134">67</xref></sup>
<italic>CACNA1c</italic> is ubiquitously expressed and has embryological importance, highlighted by the diverse congenital TS manifestations, including seizures, cognitive disability, electrolyte derangements, and hypoglycemia.<sup><xref ref-type="bibr" rid="bibr67-1179546817698134">67</xref>,<xref ref-type="bibr" rid="bibr76-1179546817698134">76</xref>,<xref ref-type="bibr" rid="bibr77-1179546817698134">77</xref></sup> Polymorphisms in <italic>CACNA1c</italic> may also play a role in valvular heart disease<sup><xref ref-type="bibr" rid="bibr78-1179546817698134">78</xref></sup> and psychiatric disease.<sup><xref ref-type="bibr" rid="bibr79-1179546817698134">79</xref></sup></p>
<p>Andersen-Tawil syndrome (ATS) (classified as LQT7) is an autosomal dominant syndrome classically defined by the triad of episodic flaccid paralysis, QTc prolongation, and congenital morphological anomalies.<sup><xref ref-type="bibr" rid="bibr80-1179546817698134">80</xref></sup> In actuality, ATS is better defined by its characteristic T-U wave patterns than by QT prolongation, which is usually absent.<sup><xref ref-type="bibr" rid="bibr80-1179546817698134">80</xref></sup> Mutations in the inward-rectifying potassium channel, <italic>KCNJ2</italic>, underlie ATS,<sup><xref ref-type="bibr" rid="bibr68-1179546817698134">68</xref></sup> as well as isolated cases of SQTS<sup><xref ref-type="bibr" rid="bibr81-1179546817698134">81</xref></sup> and CPVT.<sup><xref ref-type="bibr" rid="bibr82-1179546817698134">82</xref></sup> In fact, the bidirectional VT characteristic of ATS is a phenocopy of CPVT, and both conditions appear to respond well to Na<sup>+</sup> channel antagonists,<sup><xref ref-type="bibr" rid="bibr59-1179546817698134">59</xref>,<xref ref-type="bibr" rid="bibr83-1179546817698134">83</xref></sup> suggesting the possibility of a shared mechanism.</p>
</sec>
<sec id="section9-1179546817698134">
<title>The role of SCN5A in gastrointestinal motility</title>
<p><italic>SCN5A</italic>-encoded Na<sub>v</sub>1.5 has been identified in gastrointestinal (GI) smooth muscle cells<sup><xref ref-type="bibr" rid="bibr84-1179546817698134">84</xref></sup> and interstitial cells of Cajal,<sup><xref ref-type="bibr" rid="bibr85-1179546817698134">85</xref></sup> raising suspicion that the familial preponderance of certain GI diseases could be attributable to heritable Na<sup>+</sup> channel defects. Subsequent functional and animal studies confirmed the importance of <italic>SCN5A</italic> in GI motility,<sup><xref ref-type="bibr" rid="bibr86-1179546817698134">86</xref></sup> and <italic>SCN5A</italic> variants are now thought to underlie human GI syndromes,<sup><xref ref-type="bibr" rid="bibr87-1179546817698134">87</xref></sup> including reports of overlapping GI and BrS phenotypes.<sup><xref ref-type="bibr" rid="bibr88-1179546817698134">88</xref></sup> This example highlights the importance of pursuing comprehensive evaluations in all patients, as yet unrecognized syndromes may relate to the ion channel genes.</p>
</sec>
<sec id="section10-1179546817698134">
<title>Glucose control in CPVT patients with RYR2 mutations</title>
<p><italic>RYR2</italic> is ubiquitously expressed in a variety of tissues, including the brain and pancreas.<sup><xref ref-type="bibr" rid="bibr89-1179546817698134">89</xref></sup> Using oral glucose tolerance testing, Santulli et al<sup><xref ref-type="bibr" rid="bibr90-1179546817698134">90</xref></sup> found that patients with CPVT have impaired glucose regulation, likely related to RyR2 dysfunction. They recapitulated this phenotype in CPVT mice and then rescued β-cell function in vitro using small molecules that stabilize RyR2, called “Rycals.”<sup><xref ref-type="bibr" rid="bibr90-1179546817698134">90</xref></sup> Rycals have not been studied in human CPVT but do offer hope that genotype-specific treatments are possible.<sup><xref ref-type="bibr" rid="bibr48-1179546817698134">48</xref></sup></p>
</sec>
<sec id="section11-1179546817698134">
<title>Epilepsy</title>
<p>Ventricular arrhythmias can cause hypoxemic seizures, including reports of cardiac ion channelopathy masquerading as epilepsy.<sup><xref ref-type="bibr" rid="bibr14-1179546817698134">14</xref>,<xref ref-type="bibr" rid="bibr91-1179546817698134">91</xref></sup> The possibility of arrhythmic syncope must be considered in all patients with unexplained seizure, with a careful focus on the electrocardiogram and history. However, seizures can occur independent of arrhythmia in patients with channelopathy. <italic>KCNQ1</italic> channels are expressed in both neural and cardiac tissue,<sup><xref ref-type="bibr" rid="bibr13-1179546817698134">13</xref></sup> and primary epilepsy and LQTS have been reported to coexist in 1 LQT1 family.<sup><xref ref-type="bibr" rid="bibr92-1179546817698134">92</xref></sup> This relationship extends to LQT2,<sup><xref ref-type="bibr" rid="bibr14-1179546817698134">14</xref></sup> in which seizures may be even more prevalent.<sup><xref ref-type="bibr" rid="bibr93-1179546817698134">93</xref></sup> Recently, whole exome sequencing of SUD in epilepsy victims revealed several rare LQTS variants.<sup><xref ref-type="bibr" rid="bibr15-1179546817698134">15</xref></sup> Animal models further support evidence of a phenotypic overlap.<sup><xref ref-type="bibr" rid="bibr69-1179546817698134">69</xref></sup> In ATS,<sup><xref ref-type="bibr" rid="bibr71-1179546817698134">71</xref></sup> BrS,<sup><xref ref-type="bibr" rid="bibr72-1179546817698134">72</xref></sup> and CPVT,<sup><xref ref-type="bibr" rid="bibr70-1179546817698134">70</xref></sup> this phenomenon may also exist, making c<italic>ardiocerebral-channelopathy overlap syndrome</italic><sup><xref ref-type="bibr" rid="bibr91-1179546817698134">91</xref></sup> a suitable all-encompassing term. We recommend that cardiologists and neurologists pursue detailed phenotyping in patients with arrhythmias and seizures (<xref ref-type="fig" rid="fig1-1179546817698134">Figure 1</xref>) so as not to miss this unifying syndrome.</p>
<fig id="fig1-1179546817698134" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Simplified algorithm for the assessment of a potential ion channel overlap syndrome.</p>
</caption>
<graphic xlink:href="10.1177_1179546817698134-fig1"></graphic>
</fig>
</sec>
</sec>
<sec id="section12-1179546817698134" sec-type="conclusions">
<title>Conclusions</title>
<p>Mutations in the ion channel genes underlie a variety of phenotypes that extend beyond the electrocardiogram, ranging from overt, life-threatening symptoms, to concealed, benign pathology. The most recognized overlapping manifestations include cardiomyopathy and the systemic features of LQTS, almost all of which were described before the modern molecular era. So far, no unifying mechanism exists to explain these syndromes, and a variety of additional factors may influence gene expression in ion channel diseases, such as epigenetic factors in cancer proliferation,<sup><xref ref-type="bibr" rid="bibr94-1179546817698134">94</xref></sup> genetic compartmentalization in heart disease,<sup><xref ref-type="bibr" rid="bibr95-1179546817698134">95</xref></sup> and posttranslational modifications in epilepsy.<sup><xref ref-type="bibr" rid="bibr96-1179546817698134">96</xref></sup> The ion channels interact with one another, and disruption of one channel may induce dysfunction in another, as has been shown with Ca<sup>2+</sup> regulation in LQTS models.<sup><xref ref-type="bibr" rid="bibr97-1179546817698134">97</xref></sup> In many of these examples, genetic causation may be questionable,<sup><xref ref-type="bibr" rid="bibr98-1179546817698134">98</xref></sup> and genetic testing is probabilistic in nature.<sup><xref ref-type="bibr" rid="bibr99-1179546817698134">99</xref></sup> We propose an assessment model (<xref ref-type="fig" rid="fig1-1179546817698134">Figure 1</xref>) that emphasizes the multidisciplinary care required to evaluate these syndromes. In the future, improved clinical recognition will inform further molecular studies on the mechanistic basis of the nonarrhythmic phenotypes.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<caption>
<title>Supplementary material</title>
</caption>
<media id="d35e1497" mime-subtype="pdf" mimetype="application" orientation="portrait" position="anchor" xlink:href="f_SupplementaryMaterial_698134_8633.pdf"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The authors thank Ms. Frances Perry for assisting with reference material.</p>
</ack>
<fn-group>
<fn fn-type="other">
<p><bold>Peer review:</bold>Five peer reviewers contributed to the peer review report. Reviewers’ reports totaled 1532 words, excluding any confidential comments to the academic editor.</p>
</fn>
<fn fn-type="financial-disclosure">
<p><bold>Funding:</bold>The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Drs. Roston and Sanatani received funding from the Rare Disease Foundation and BC Children’s Hospital Foundation. Drs. Krahn and Sanatani are supported by the Heart and Stroke Foundation of Canada (G-13-0002775 and G-14-0005732 to ADK and G-15-0008870 to SS). Dr. Krahn is also supported by the Sauder Family and Heart and Stroke Foundation Chair in Cardiology and the Paul Brunes Chair in Heart Rhythm Disorders. Dr. Laksman is the UBC Dr. Charles Kerr Distinguished Scholar in Cardiovascular Genetics.</p>
</fn>
<fn fn-type="COI-statement">
<p><bold>Declaration of conflicting interests:</bold>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="other">
<p><bold>Author Contributions:</bold> TMR conducted the literature review and wrote the manuscript. TC conducted the literature review, drafted portions of the manuscript and assisted with reference material. AL conceived the review topic and revised the manuscript. ZWL provided revisions and reference material for the manuscript. ADK conceived the review topic, and provided revisions and reference material for the manuscript. SS conceived the review topic, supervised the first author, assisted with revisions and approved of the final version of the manuscript.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1179546817698134">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Neyround</surname><given-names>N</given-names></name><name><surname>Tesson</surname><given-names>F</given-names></name><name><surname>Denjoy</surname><given-names>I</given-names></name><etal></etal></person-group>
<article-title>A novel mutation in the potassium channel gene <italic>KVLQT1</italic> causes the Jervell and Lange-Nielsen cardioauditory syndrome</article-title>. <source/>Nat Genet. <year>1997</year>;<volume>15</volume>:<fpage>186</fpage>–<lpage>189</lpage>.<pub-id pub-id-type="pmid">9020846</pub-id></mixed-citation>
</ref>
<ref id="bibr2-1179546817698134">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jervell</surname><given-names>A</given-names></name><name><surname>Lange-Nielsen</surname><given-names>F.</given-names></name></person-group>
<article-title>Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death</article-title>. <source/>Am Heart J. <year>1957</year>;<volume>54</volume>:<fpage>59</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">13435203</pub-id></mixed-citation>
</ref>
<ref id="bibr3-1179546817698134">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Priori</surname><given-names>SG</given-names></name><name><surname>Wilde</surname><given-names>AA</given-names></name><name><surname>Horie</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes</article-title>. <source/>Heart Rhythm. <year>2013</year>;<volume>10</volume>:<fpage>1932</fpage>–<lpage>1963</lpage>.<pub-id pub-id-type="pmid">24011539</pub-id></mixed-citation>
</ref>
<ref id="bibr4-1179546817698134">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amin</surname><given-names>AS</given-names></name><name><surname>Giudicessi</surname><given-names>JR</given-names></name><name><surname>Tijsen</surname><given-names>AJ</given-names></name><etal></etal></person-group>
<article-title>Variants in the 3′ untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner</article-title>. <source/>Eur Heart J. <year>2012</year>;<volume>33</volume>:<fpage>714</fpage>–<lpage>723</lpage>.<pub-id pub-id-type="pmid">22199116</pub-id></mixed-citation>
</ref>
<ref id="bibr5-1179546817698134">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mazzanti</surname><given-names>A</given-names></name><name><surname>Maragna</surname><given-names>R</given-names></name><name><surname>Faragli</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3</article-title>. <source/>J Am Coll Cardiol. <year>2016</year>;<volume>67</volume>:<fpage>1053</fpage>–<lpage>1058</lpage>.<pub-id pub-id-type="pmid">26940925</pub-id></mixed-citation>
</ref>
<ref id="bibr6-1179546817698134">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>JF</given-names></name><name><surname>Moss</surname><given-names>AJ</given-names></name><name><surname>Jons</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Mutation-specific risk in two genetic forms of type 3 long QT syndrome</article-title>. <source/>Am J Cardiol. <year>2010</year>;<volume>105</volume>:<fpage>210</fpage>–<lpage>213</lpage>.<pub-id pub-id-type="pmid">20102920</pub-id></mixed-citation>
</ref>
<ref id="bibr7-1179546817698134">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tiso</surname><given-names>N</given-names></name><name><surname>Stephan</surname><given-names>D</given-names></name><name><surname>Nava</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)</article-title>. <source/>Hum Mol Genet. <year>2001</year>;<volume>10</volume>:<fpage>189</fpage>–<lpage>194</lpage>.<pub-id pub-id-type="pmid">11159936</pub-id></mixed-citation>
</ref>
<ref id="bibr8-1179546817698134">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McNair</surname><given-names>WP</given-names></name><name><surname>Ku</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>MR</given-names></name><etal></etal></person-group>
<article-title><italic>SCN5A</italic> mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia</article-title>. <source/>Circulation. <year>2004</year>;<volume>110</volume>:<fpage>2163</fpage>–<lpage>2167</lpage>.<pub-id pub-id-type="pmid">15466643</pub-id></mixed-citation>
</ref>
<ref id="bibr9-1179546817698134">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McNair</surname><given-names>WP</given-names></name><name><surname>Sinagra</surname><given-names>G</given-names></name><name><surname>Taylor</surname><given-names>MR</given-names></name><etal></etal></person-group>
<article-title><italic>SCN5A</italic> mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism</article-title>. <source/>J Am Coll Cardiol. <year>2011</year>;<volume>57</volume>:<fpage>2160</fpage>–<lpage>2168</lpage>.<pub-id pub-id-type="pmid">21596231</pub-id></mixed-citation>
</ref>
<ref id="bibr10-1179546817698134">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Omura</surname><given-names>M</given-names></name><name><surname>Kawamura</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Exon 3 deletion of <italic>RYR2</italic> encoding cardiac ryanodine receptor is associated with left ventricular non-compaction</article-title>. <source/>Europace. <year>2014</year>;<volume>16</volume>:<fpage>1646</fpage>–<lpage>1654</lpage>.<pub-id pub-id-type="pmid">24394973</pub-id></mixed-citation>
</ref>
<ref id="bibr11-1179546817698134">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frea</surname><given-names>S</given-names></name><name><surname>Giustetto</surname><given-names>C</given-names></name><name><surname>Capriolo</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>New echocardiographic insights in short QT syndrome: more than a channelopathy?</article-title>
<source/>Heart Rhythm. <year>2015</year>;<volume>10</volume>:<fpage>2096</fpage>–<lpage>2105</lpage>.</mixed-citation>
</ref>
<ref id="bibr12-1179546817698134">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Campbell</surname><given-names>MJ</given-names></name><name><surname>Czosek</surname><given-names>RJ</given-names></name><name><surname>Hinton</surname><given-names>RB</given-names></name><name><surname>Miller</surname><given-names>EM.</given-names></name></person-group>
<article-title>Exon 3 deletion of ryanodine receptor causes left ventricular noncompaction, worsening catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest</article-title>. <source/>Am J Med Genet A. <year>2015</year>;<volume>167A</volume>:<fpage>2197</fpage>–<lpage>2200</lpage>.<pub-id pub-id-type="pmid">26018045</pub-id></mixed-citation>
</ref>
<ref id="bibr13-1179546817698134">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnson</surname><given-names>JN</given-names></name><name><surname>Hofman</surname><given-names>N</given-names></name><name><surname>Haglund</surname><given-names>CM</given-names></name><name><surname>Cascino</surname><given-names>GD</given-names></name><name><surname>Wilde</surname><given-names>AAM</given-names></name><name><surname>Ackerman</surname><given-names>MJ.</given-names></name></person-group>
<article-title>Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy</article-title>. <source/>Neurology. <year>2009</year>;<volume>72</volume>:<fpage>224</fpage>–<lpage>231</lpage>.<pub-id pub-id-type="pmid">19038855</pub-id></mixed-citation>
</ref>
<ref id="bibr14-1179546817698134">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zamorano-Leon</surname><given-names>JJ</given-names></name><name><surname>Yanez</surname><given-names>R</given-names></name><name><surname>Jaime</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>KCNH2 gene mutation: a potential link between epilepsy and long QT-2 syndrome</article-title>. <source/>J Neurogenet. <year>2012</year>;<volume>26</volume>:<fpage>382</fpage>–<lpage>386</lpage>.<pub-id pub-id-type="pmid">22515331</pub-id></mixed-citation>
</ref>
<ref id="bibr15-1179546817698134">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bagnall</surname><given-names>RD</given-names></name><name><surname>Crompton</surname><given-names>DE</given-names></name><name><surname>Petrovski</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Exome-based analysis of cardiac arrhythmia, respiratory control, and epilepsy genes in sudden unexpected death in epilepsy</article-title>. <source/>Ann Neurol. <year>2016</year>;<volume>79</volume>:<fpage>522</fpage>–<lpage>534</lpage>.<pub-id pub-id-type="pmid">26704558</pub-id></mixed-citation>
</ref>
<ref id="bibr16-1179546817698134">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakashima</surname><given-names>K</given-names></name><name><surname>Kusakawa</surname><given-names>I</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Left ventricular noncompaction in a patient with long QT syndrome caused by a <italic>KCNQ1</italic> mutation: a case report</article-title>. <source/>Heart Vessels. <year>2013</year>;<volume>28</volume>:<fpage>126</fpage>–<lpage>129</lpage>.<pub-id pub-id-type="pmid">22354620</pub-id></mixed-citation>
</ref>
<ref id="bibr17-1179546817698134">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roston</surname><given-names>TM</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Krahn</surname><given-names>AD</given-names></name><etal></etal></person-group>
<article-title>A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia [published online ahead of print September 8, 2016]</article-title>. <source/>J Electrocardiol. doi:<pub-id pub-id-type="doi">10.1016/j.jelectrocard.2016.09.006.</pub-id></mixed-citation>
</ref>
<ref id="bibr18-1179546817698134">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Milano</surname><given-names>A</given-names></name><name><surname>Vermeer</surname><given-names>AM</given-names></name><name><surname>Lodder</surname><given-names>EM</given-names></name><etal></etal></person-group>
<article-title><italic>HCN4</italic> mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy</article-title>. <source/>J Am Coll Cardiol. <year>2014</year>;<volume>64</volume>:<fpage>745</fpage>–<lpage>756</lpage>.<pub-id pub-id-type="pmid">25145517</pub-id></mixed-citation>
</ref>
<ref id="bibr19-1179546817698134">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roux-Buisson</surname><given-names>N</given-names></name><name><surname>Gandjbakhch</surname><given-names>E</given-names></name><name><surname>Donal</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Prevalence and significance of rare RYR2 variants in arrhythmogenic right ventricular cardiomyopathy/dysplasia: results of a systematic screening</article-title>. <source/>Heart Rhythm. <year>2014</year>;<volume>11</volume>:<fpage>1999</fpage>–<lpage>2009</lpage>.<pub-id pub-id-type="pmid">25041964</pub-id></mixed-citation>
</ref>
<ref id="bibr20-1179546817698134">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nair</surname><given-names>K</given-names></name><name><surname>Pekhletski</surname><given-names>R</given-names></name><name><surname>Harris</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Escape capture bigeminy: phenotypic marker of cardiac sodium channel voltage sensor mutation R222Q</article-title>. <source/>Heart Rhythm. <year>2012</year>;<volume>9</volume>:<fpage>1681.e1</fpage>–<lpage>1688.e1</lpage>.<pub-id pub-id-type="pmid">22710484</pub-id></mixed-citation>
</ref>
<ref id="bibr21-1179546817698134">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gosselin-Badaroudine</surname><given-names>P</given-names></name><name><surname>Keller</surname><given-names>DI</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>A proton leak current through the cardiac sodium channel is linked to mixed arrhythmia and the dilated cardiomyopathy phenotype</article-title>. <source/>PLoS ONE. <year>2012</year>;<volume>7</volume>:<fpage>e38331</fpage>.<pub-id pub-id-type="pmid">22675453</pub-id></mixed-citation>
</ref>
<ref id="bibr22-1179546817698134">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Morales</surname><given-names>A</given-names></name><name><surname>Siegfried</surname><given-names>JD</given-names></name><etal></etal></person-group>
<article-title><italic>SCN5A</italic> rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del</article-title>. <source/>Clin Transl Sci. <year>2010</year>;<volume>3</volume>:<fpage>287</fpage>–<lpage>294</lpage>.<pub-id pub-id-type="pmid">21167004</pub-id></mixed-citation>
</ref>
<ref id="bibr23-1179546817698134">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiong</surname><given-names>Q</given-names></name><name><surname>Cao</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><etal></etal></person-group>
<article-title>Arrhythmogenic cardiomyopathy in a patient with a rare loss-of-function <italic>KCNQ1</italic> mutation</article-title>. <source/>J Am Heart Assoc. <year>2015</year>;<volume>4</volume>:<fpage>e001526</fpage>.<pub-id pub-id-type="pmid">25616976</pub-id></mixed-citation>
</ref>
<ref id="bibr24-1179546817698134">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sommariva</surname><given-names>E</given-names></name><name><surname>Pappone</surname><given-names>C</given-names></name><name><surname>Martinelli Boneschi</surname><given-names>F</given-names></name><etal></etal></person-group>
<article-title>Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification</article-title>. <source/>Eur J Hum Genet. <year>2013</year>;<volume>21</volume>:<fpage>911</fpage>–<lpage>917</lpage>.<pub-id pub-id-type="pmid">23321620</pub-id></mixed-citation>
</ref>
<ref id="bibr25-1179546817698134">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Makiyama</surname><given-names>T</given-names></name><name><surname>Wuriyanghai</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction</article-title>. <source/>Heart Rhythm. <year>2016</year>;<volume>13</volume>:<fpage>289</fpage>–<lpage>298</lpage>.<pub-id pub-id-type="pmid">26282245</pub-id></mixed-citation>
</ref>
<ref id="bibr26-1179546817698134">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Swan</surname><given-names>H</given-names></name><name><surname>Amarouch</surname><given-names>M</given-names></name><name><surname>Leinonen</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>A gain-of-function mutation of the <italic>SCN5A</italic> gene causes exercise-induced polymorphic ventricular arrhythmias</article-title>. <source/>Circ Cardiovasc Genet. <year>2014</year>;<volume>7</volume>:<fpage>771</fpage>–<lpage>781</lpage>.<pub-id pub-id-type="pmid">25210054</pub-id></mixed-citation>
</ref>
<ref id="bibr27-1179546817698134">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beaufort-Krol</surname><given-names>GC</given-names></name><name><surname>van den Berg</surname><given-names>MP</given-names></name><name><surname>Wilde</surname><given-names>AA</given-names></name><etal></etal></person-group>
<article-title>Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood</article-title>. <source/>J Am Coll Cardiol. <year>2005</year>;<volume>46</volume>:<fpage>331</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">16022964</pub-id></mixed-citation>
</ref>
<ref id="bibr28-1179546817698134">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hong</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Brugada</surname><given-names>R.</given-names></name></person-group>
<article-title>Concomitant Brugada-like and short QT electrocardiogram linked to SCN5A mutation</article-title>. <source/>Eur J Hum Genet. <year>2012</year>;<volume>20</volume>:<fpage>1189</fpage>–<lpage>1192</lpage>.<pub-id pub-id-type="pmid">22490985</pub-id></mixed-citation>
</ref>
<ref id="bibr29-1179546817698134">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bezzina</surname><given-names>CR</given-names></name><name><surname>Barc</surname><given-names>J</given-names></name><name><surname>Mizusawa</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Common variants at <italic>SCN5A-SCN10A</italic> and <italic>HEY2</italic> are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death</article-title>. <source/>Nat Genet. <year>2013</year>;<volume>45</volume>:<fpage>1044</fpage>–<lpage>1049</lpage>.<pub-id pub-id-type="pmid">23872634</pub-id></mixed-citation>
</ref>
<ref id="bibr30-1179546817698134">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schott</surname><given-names>J</given-names></name><name><surname>Alshinawi</surname><given-names>C</given-names></name><name><surname>Kyndt</surname><given-names>F</given-names></name><etal></etal></person-group>
<article-title>Cardiac conduction defects associate with mutations in <italic>SCN5A</italic></article-title>. <source/>Nat Genet. <year>1999</year>;<volume>23</volume>:<fpage>20</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">10471492</pub-id></mixed-citation>
</ref>
<ref id="bibr31-1179546817698134">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bezzina</surname><given-names>CR</given-names></name><name><surname>Rook</surname><given-names>MB</given-names></name><name><surname>Groenewegen</surname><given-names>WA</given-names></name><etal></etal></person-group>
<article-title>Compound heterozygosity for mutations (W156X and R225W) in <italic>SCN5A</italic> associated with severe cardiac conduction disturbances and degenerative changes in the conduction system</article-title>. <source/>Circ Res. <year>2003</year>;<volume>92</volume>:<fpage>159</fpage>–<lpage>168</lpage>.<pub-id pub-id-type="pmid">12574143</pub-id></mixed-citation>
</ref>
<ref id="bibr32-1179546817698134">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mann</surname><given-names>SA</given-names></name><name><surname>Castro</surname><given-names>ML</given-names></name><name><surname>Ohanian</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>R222Q <italic>SCN5A</italic> mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy</article-title>. <source/>J Am Coll Cardiol. <year>2012</year>;<volume>60</volume>:<fpage>1566</fpage>–<lpage>1573</lpage>.<pub-id pub-id-type="pmid">22999724</pub-id></mixed-citation>
</ref>
<ref id="bibr33-1179546817698134">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Towbin</surname><given-names>J</given-names></name><name><surname>Lorts</surname><given-names>A.</given-names></name></person-group>
<article-title>Arrhythmias and dilated cardiomyopathy</article-title>. <source/>J Am Coll Cardiol. <year>2011</year>;<volume>57</volume>:<fpage>2169</fpage>–<lpage>2171</lpage>.<pub-id pub-id-type="pmid">21596232</pub-id></mixed-citation>
</ref>
<ref id="bibr34-1179546817698134">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Corrado</surname><given-names>D</given-names></name><name><surname>Zorzi</surname><given-names>A</given-names></name><name><surname>Cerrone</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Relationship between arrhythmogenic right ventricular cardiomyopathy and Brugada syndrome: new insight from molecular biology and clinical implications</article-title>. <source/>Circ Arrhythm Electrophysiol. <year>2016</year>;<volume>9</volume>:<fpage>e003631</fpage>.<pub-id pub-id-type="pmid">26987567</pub-id></mixed-citation>
</ref>
<ref id="bibr35-1179546817698134">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sato</surname><given-names>PY</given-names></name><name><surname>Musa</surname><given-names>H</given-names></name><name><surname>Coombs</surname><given-names>W</given-names></name><etal></etal></person-group>
<article-title>Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes</article-title>. <source/>Circ Res. <year>2009</year>;<volume>105</volume>:<fpage>523</fpage>–<lpage>526</lpage>.<pub-id pub-id-type="pmid">19661460</pub-id></mixed-citation>
</ref>
<ref id="bibr36-1179546817698134">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cerrone</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype</article-title>. <source/>Circulation. <year>2014</year>;<volume>129</volume>:<fpage>1092</fpage>–<lpage>1103</lpage>.<pub-id pub-id-type="pmid">24352520</pub-id></mixed-citation>
</ref>
<ref id="bibr37-1179546817698134">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Pappone</surname><given-names>C</given-names></name><name><surname>Berruezo</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Brugada syndrome phenotype elimination by epicardial substrate ablation</article-title>. <source/>Circ Arrhythm Electrophysiol. <year>2015</year>;<volume>8</volume>:<fpage>1373</fpage>–<lpage>1381</lpage>.<pub-id pub-id-type="pmid">26291334</pub-id></mixed-citation>
</ref>
<ref id="bibr38-1179546817698134">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Tung</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><etal></etal></person-group>
<article-title>Characterization of the epicardial substrate for catheter ablation of Brugada syndrome</article-title>. <source/>Heart Rhythm. <year>2016</year>;<volume>13</volume>:<fpage>2151</fpage>–<lpage>2158</lpage>.<pub-id pub-id-type="pmid">27453126</pub-id></mixed-citation>
</ref>
<ref id="bibr39-1179546817698134">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Veerman</surname><given-names>CC</given-names></name><name><surname>Mengarelli</surname><given-names>I</given-names></name><name><surname>Guan</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>hiPSC-derived cardiomyocytes from Brugada syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities</article-title>. <source/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>30967</fpage>.<pub-id pub-id-type="pmid">27485484</pub-id></mixed-citation>
</ref>
<ref id="bibr40-1179546817698134">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hong</surname><given-names>K</given-names></name><name><surname>Piper</surname><given-names>DR</given-names></name><name><surname>Diaz-Valdecantos</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>De novo <italic>KCNQ1</italic> mutation responsible for atrial fibrillation and short QT syndrome in utero</article-title>. <source/>Cardiovasc Res. <year>2005</year>;<volume>68</volume>:<fpage>433</fpage>–<lpage>440</lpage>.<pub-id pub-id-type="pmid">16109388</pub-id></mixed-citation>
</ref>
<ref id="bibr41-1179546817698134">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Xu</surname><given-names>SJ</given-names></name><name><surname>Bendahhou</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title><italic>KCNQ1</italic> gain-of-function mutation in familial atrial fibrillation</article-title>. <source/>Science. <year>2003</year>;<volume>299</volume>:<fpage>251</fpage>–<lpage>254</lpage>.<pub-id pub-id-type="pmid">12522251</pub-id></mixed-citation>
</ref>
<ref id="bibr42-1179546817698134">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Terano</surname><given-names>K</given-names></name><name><surname>Ando</surname><given-names>T</given-names></name><name><surname>Hishitani</surname><given-names>T</given-names></name><name><surname>Hoshino</surname><given-names>K.</given-names></name></person-group>
<article-title>Isolated non-compaction of the ventricular myocardium associated with long QT syndrome: a report of 2 cases</article-title>. <source/>Circ J. <year>2009</year>;<volume>73</volume>:<fpage>2169</fpage>–<lpage>2172</lpage>.<pub-id pub-id-type="pmid">19352046</pub-id></mixed-citation>
</ref>
<ref id="bibr43-1179546817698134">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shan</surname><given-names>L</given-names></name><name><surname>Makita</surname><given-names>N</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title><italic>SCN5A</italic> variants in Japanese patients with left ventricular noncompaction and arrhythmia</article-title>. <source/>Mol Genet Metab. <year>2007</year>;<volume>93</volume>:<fpage>468</fpage>–<lpage>474</lpage>.</mixed-citation>
</ref>
<ref id="bibr44-1179546817698134">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sarquella-Brugada</surname><given-names>G</given-names></name><name><surname>Campuzano</surname><given-names>O</given-names></name><name><surname>Iglesias</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Short QT and atrial fibrillation: a <italic>KCNQ1</italic> mutation-specific disease. Late follow-up in three unrelated children</article-title>. <source/>Heart Rhythm Case Rep. <year>2015</year>;<volume>1</volume>:<fpage>193</fpage>–<lpage>197</lpage>.</mixed-citation>
</ref>
<ref id="bibr45-1179546817698134">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanemoto</surname><given-names>N</given-names></name><name><surname>Horigome</surname><given-names>H</given-names></name><name><surname>Nakayama</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Interstitial 1q43-q43 deletion with left ventricular noncompaction myocardium</article-title>. <source/>Eur J Med Genet. <year>2006</year>;<volume>49</volume>:<fpage>247</fpage>–<lpage>253</lpage>.<pub-id pub-id-type="pmid">16762826</pub-id></mixed-citation>
</ref>
<ref id="bibr46-1179546817698134">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davies</surname><given-names>MP</given-names></name><name><surname>An</surname><given-names>RH</given-names></name><name><surname>Doevendans</surname><given-names>P</given-names></name><name><surname>Kubalak</surname><given-names>S</given-names></name><name><surname>Chien</surname><given-names>KR</given-names></name><name><surname>Kass</surname><given-names>RS.</given-names></name></person-group>
<article-title>Developmental changes in ionic channel activity in the embryonic murine heart</article-title>. <source/>Circ Res. <year>1996</year>;<volume>78</volume>:<fpage>15</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">8603498</pub-id></mixed-citation>
</ref>
<ref id="bibr47-1179546817698134">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Priori</surname><given-names>SG</given-names></name><name><surname>Napolitano</surname><given-names>C</given-names></name><name><surname>Tiso</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Mutations in the cardiac ryanodine receptor gene <italic>(hRyR2)</italic> underlie catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Circulation. <year>2001</year>;<volume>103</volume>:<fpage>196</fpage>–<lpage>200</lpage>.<pub-id pub-id-type="pmid">11208676</pub-id></mixed-citation>
</ref>
<ref id="bibr48-1179546817698134">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roston</surname><given-names>TM</given-names></name><name><surname>Van Petegem</surname><given-names>F</given-names></name><name><surname>Sanatani</surname><given-names>S.</given-names></name></person-group>
<article-title>Catecholaminergic polymorphic ventricular tachycardia: a model for genotype-specific therapy</article-title>. <source/>Curr Opin Cardiol. <year>2017</year>;<volume>32</volume>:<fpage>78</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">27861184</pub-id></mixed-citation>
</ref>
<ref id="bibr49-1179546817698134">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Priori</surname><given-names>SG</given-names></name><name><surname>Chen</surname><given-names>SR.</given-names></name></person-group>
<article-title>Inherited dysfunction of sarcoplasmic reticulum Ca<sup>2+</sup> handling and arrhythmogenesis</article-title>. <source/>Circ Res. <year>2011</year>;<volume>108</volume>:<fpage>871</fpage>–<lpage>883</lpage>.<pub-id pub-id-type="pmid">21454795</pub-id></mixed-citation>
</ref>
<ref id="bibr50-1179546817698134">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roston</surname><given-names>TM</given-names></name><name><surname>Sanatani</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>SR.</given-names></name></person-group>
<article-title>Suppression-of-function mutations in the cardiac ryanodine receptor: emerging evidence for a novel arrhythmia syndrome?</article-title>
<source/>Heart Rhythm. <year>2017</year>;<volume>14</volume>:<fpage>108</fpage>–<lpage>109</lpage>.<pub-id pub-id-type="pmid">27818320</pub-id></mixed-citation>
</ref>
<ref id="bibr51-1179546817698134">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fujii</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>H</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>A type 2 ryanodine receptor variant associated with reduced Ca<sup>2+</sup> release and short-coupled torsades de pointes ventricular arrhythmia</article-title>. <source/>Heart Rhythm. <year>2017</year>;<volume>14</volume>:<fpage>98</fpage>–<lpage>107</lpage>.<pub-id pub-id-type="pmid">27756708</pub-id></mixed-citation>
</ref>
<ref id="bibr52-1179546817698134">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paech</surname><given-names>C</given-names></name><name><surname>Gebauer</surname><given-names>RA</given-names></name><name><surname>Karstedt</surname><given-names>J</given-names></name><name><surname>Marschall</surname><given-names>C</given-names></name><name><surname>Bollmann</surname><given-names>A</given-names></name><name><surname>Husser</surname><given-names>D.</given-names></name></person-group>
<article-title>Ryanodine receptor mutations presenting as idiopathic ventricular fibrillation: a report on two novel familial compound mutations, c.6224T&gt;C and c.13781A&gt;G, with the clinical presentation of idiopathic ventricular fibrillation</article-title>. <source/>Pediatr Cardiol. <year>2014</year>;<volume>35</volume>:<fpage>1437</fpage>–<lpage>1441</lpage>.<pub-id pub-id-type="pmid">24950728</pub-id></mixed-citation>
</ref>
<ref id="bibr53-1179546817698134">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kreusser</surname><given-names>MM</given-names></name><name><surname>Lehmann</surname><given-names>LH</given-names></name><name><surname>Keranov</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy</article-title>. <source/>Circulation. <year>2014</year>;<volume>130</volume>:<fpage>1262</fpage>–<lpage>1273</lpage>.<pub-id pub-id-type="pmid">25124496</pub-id></mixed-citation>
</ref>
<ref id="bibr54-1179546817698134">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marcus</surname><given-names>F</given-names></name><name><surname>McKenna</surname><given-names>W</given-names></name><name><surname>Sherrill</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia</article-title>. <source/>Circulation. <year>2010</year>;<volume>121</volume>:<fpage>1533</fpage>–<lpage>1541</lpage>.<pub-id pub-id-type="pmid">20172911</pub-id></mixed-citation>
</ref>
<ref id="bibr55-1179546817698134">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basso</surname><given-names>C</given-names></name><name><surname>Corrado</surname><given-names>D</given-names></name><name><surname>Marcus</surname><given-names>FI</given-names></name><name><surname>Nava</surname><given-names>A</given-names></name><name><surname>Thiene</surname><given-names>G.</given-names></name></person-group>
<article-title>Arrhythmogenic right ventricular cardiomyopathy</article-title>. <source/>Lancet. <year>2009</year>;<volume>373</volume>:<fpage>1289</fpage>–<lpage>1300</lpage>.<pub-id pub-id-type="pmid">19362677</pub-id></mixed-citation>
</ref>
<ref id="bibr56-1179546817698134">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asimaki</surname><given-names>A</given-names></name><name><surname>Tandri</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy</article-title>. <source/>N Engl J Med. <year>2009</year>;<volume>360</volume>:<fpage>1075</fpage>–<lpage>1084</lpage>.<pub-id pub-id-type="pmid">19279339</pub-id></mixed-citation>
</ref>
<ref id="bibr57-1179546817698134">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kleber</surname><given-names>AG</given-names></name><name><surname>Saffitz</surname><given-names>JE.</given-names></name></person-group>
<article-title>Role of the intercalated disc in cardiac propagation and arrhythmogenesis</article-title>. <source/>Front Physiol. <year>2014</year>;<volume>5</volume>:<fpage>404</fpage>.<pub-id pub-id-type="pmid">25368581</pub-id></mixed-citation>
</ref>
<ref id="bibr58-1179546817698134">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jabbari</surname><given-names>J</given-names></name><name><surname>Jabbari</surname><given-names>R</given-names></name><name><surname>Nielsen</surname><given-names>MW</given-names></name><etal></etal></person-group>
<article-title>New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Circ Cardiovasc Genet. <year>2013</year>;<volume>6</volume>:<fpage>481</fpage>–<lpage>489</lpage>.<pub-id pub-id-type="pmid">24025405</pub-id></mixed-citation>
</ref>
<ref id="bibr59-1179546817698134">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roston</surname><given-names>TM</given-names></name><name><surname>Vinocur</surname><given-names>JM</given-names></name><name><surname>Maginot</surname><given-names>KR</given-names></name><etal></etal></person-group>
<article-title>Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry</article-title>. <source/>Circ Arrhythm Electrophysiol. <year>2015</year>;<volume>8</volume>:<fpage>633</fpage>–<lpage>642</lpage>.<pub-id pub-id-type="pmid">25713214</pub-id></mixed-citation>
</ref>
<ref id="bibr60-1179546817698134">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schulze-Bahr</surname><given-names>E</given-names></name><name><surname>Neu</surname><given-names>A</given-names></name><name><surname>Friederich</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Pacemaker channel dysfunction in a patient with sinus node disease</article-title>. <source/>J Clin Invest. <year>2003</year>;<volume>111</volume>:<fpage>1537</fpage>–<lpage>1545</lpage>.<pub-id pub-id-type="pmid">12750403</pub-id></mixed-citation>
</ref>
<ref id="bibr61-1179546817698134">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Macri</surname><given-names>V</given-names></name><name><surname>Mahida</surname><given-names>SN</given-names></name><name><surname>Zhang</surname><given-names>ML</given-names></name><etal></etal></person-group>
<article-title>A novel trafficking-defective <italic>HCN4</italic> mutation is associated with early-onset atrial fibrillation</article-title>. <source/>Heart Rhythm. <year>2014</year>;<volume>11</volume>:<fpage>1055</fpage>–<lpage>1062</lpage>.<pub-id pub-id-type="pmid">24607718</pub-id></mixed-citation>
</ref>
<ref id="bibr62-1179546817698134">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duhme</surname><given-names>N</given-names></name><name><surname>Schweizer</surname><given-names>PA</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Altered <italic>HCN4</italic> channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation</article-title>. <source/>Eur Heart J. <year>2013</year>;<volume>34</volume>:<fpage>2768</fpage>–<lpage>2775</lpage>.<pub-id pub-id-type="pmid">23178648</pub-id></mixed-citation>
</ref>
<ref id="bibr63-1179546817698134">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spater</surname><given-names>D</given-names></name><name><surname>Abramczuk</surname><given-names>M</given-names></name><name><surname>Buac</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells</article-title>. <source/>Nat Cell Biol. <year>2013</year>;<volume>15</volume>:<fpage>1098</fpage>–<lpage>1106</lpage>.<pub-id pub-id-type="pmid">23974038</pub-id></mixed-citation>
</ref>
<ref id="bibr64-1179546817698134">
<label>64</label>
<mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Estes</surname><given-names>NA</given-names><suffix>3rd</suffix></name><name><surname>Link</surname><given-names>MS</given-names></name><name><surname>Cannom</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Report of the NASPE policy conference on arrhythmias and the athlete</article-title>. <conf-name>J Cardiovasc Electrophysiol</conf-name>
<year>2001</year>;<volume>12</volume>:<fpage>1208</fpage>–<lpage>1219</lpage>.</mixed-citation>
</ref>
<ref id="bibr65-1179546817698134">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schweizer</surname><given-names>PA</given-names></name><name><surname>Schroter</surname><given-names>J</given-names></name><name><surname>Greiner</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel</article-title>. <source/>J Am Coll Cardiol. <year>2014</year>;<volume>64</volume>:<fpage>757</fpage>–<lpage>767</lpage>.<pub-id pub-id-type="pmid">25145518</pub-id></mixed-citation>
</ref>
<ref id="bibr66-1179546817698134">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vermeer</surname><given-names>AM</given-names></name><name><surname>Lodder</surname><given-names>EM</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Dilation of the aorta ascendens forms part of the clinical spectrum of <italic>HCN4</italic> mutations</article-title>. <source/>J Am Coll Cardiol. <year>2016</year>;<volume>67</volume>:<fpage>2313</fpage>–<lpage>2315</lpage>.<pub-id pub-id-type="pmid">27173043</pub-id></mixed-citation>
</ref>
<ref id="bibr67-1179546817698134">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Splawski</surname><given-names>I</given-names></name><name><surname>Timothy</surname><given-names>K</given-names></name><name><surname>Sharpe</surname><given-names>I</given-names></name><etal></etal></person-group>
<article-title>Ca<sub>V</sub>1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism</article-title>. <source/>Cell. <year>2004</year>;<volume>119</volume>:<fpage>19</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">15454078</pub-id></mixed-citation>
</ref>
<ref id="bibr68-1179546817698134">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Plaster</surname><given-names>NM</given-names></name><name><surname>Tawil</surname><given-names>R</given-names></name><name><surname>Tristani-Firouzi</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen’s syndrome</article-title>. <source/>Cell. <year>2001</year>;<volume>105</volume>:<fpage>511</fpage>–<lpage>519</lpage>.<pub-id pub-id-type="pmid">11371347</pub-id></mixed-citation>
</ref>
<ref id="bibr69-1179546817698134">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goldman</surname><given-names>AM</given-names></name><name><surname>Glasscock</surname><given-names>E</given-names></name><name><surname>Yoo</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>TT</given-names></name><name><surname>Klassen</surname><given-names>TL</given-names></name><name><surname>Noebels</surname><given-names>JL.</given-names></name></person-group>
<article-title>Arrhythmia in heart and brain: <italic>kCNQ1</italic> mutations link epilepsy and sudden unexplained death</article-title>. <source/>Sci Transl Med. <year>2009</year>;<volume>1</volume>:2ra6.</mixed-citation>
</ref>
<ref id="bibr70-1179546817698134">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagrani</surname><given-names>T</given-names></name><name><surname>Siyamwala</surname><given-names>M</given-names></name><name><surname>Vahid</surname><given-names>G</given-names></name><name><surname>Bekheit</surname><given-names>S.</given-names></name></person-group>
<article-title>Ryanodine calcium channel: a novel channelopathy for seizures</article-title>. <source/>Neurologist. <year>2011</year>;<volume>17</volume>:<fpage>91</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">21364362</pub-id></mixed-citation>
</ref>
<ref id="bibr71-1179546817698134">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marquez</surname><given-names>M</given-names></name><name><surname>Totomoch-Serra</surname><given-names>A</given-names></name><name><surname>Burgoa</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Abnormal electroencephalogram, epileptic seizures, structural congenital heart disease and aborted sudden cardiac death in Andersen-Tawil syndrome</article-title>. <source/>Int J Cardiol. <year>2015</year>;<volume>180</volume>:<fpage>206</fpage>–<lpage>208</lpage>.<pub-id pub-id-type="pmid">25463366</pub-id></mixed-citation>
</ref>
<ref id="bibr72-1179546817698134">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sandorfi</surname><given-names>G</given-names></name><name><surname>Clemens</surname><given-names>B</given-names></name><name><surname>Csanadi</surname><given-names>Z.</given-names></name></person-group>
<article-title>Electrical storm in the brain and in the heart: epilepsy and Brugada syndrome</article-title>. <source/>Mayo Clin Proc. <year>2013</year>;<volume>88</volume>:<fpage>1167</fpage>–<lpage>1173</lpage>.<pub-id pub-id-type="pmid">24079686</pub-id></mixed-citation>
</ref>
<ref id="bibr73-1179546817698134">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Spazzolini</surname><given-names>C</given-names></name><name><surname>Crotti</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome</article-title>. <source/>Circulation. <year>2006</year>;<volume>113</volume>:<fpage>783</fpage>–<lpage>790</lpage>.<pub-id pub-id-type="pmid">16461811</pub-id></mixed-citation>
</ref>
<ref id="bibr74-1179546817698134">
<label>74</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vetter</surname><given-names>DE</given-names></name><name><surname>Mann</surname><given-names>JR</given-names></name><name><surname>Wangemann</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Inner ear defects induced by null mutation of the isk gene</article-title>. <source/>Neuron. <year>1996</year>;<volume>17</volume>:<fpage>1251</fpage>–<lpage>1264</lpage>.<pub-id pub-id-type="pmid">8982171</pub-id></mixed-citation>
</ref>
<ref id="bibr75-1179546817698134">
<label>75</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Modell</surname><given-names>SM</given-names></name><name><surname>Lehmann</surname><given-names>MH.</given-names></name></person-group>
<article-title>The long QT syndrome family of cardiac ion channelopathies: a HuGE review</article-title>. <source/>Genet Med. <year>2006</year>;<volume>8</volume>:<fpage>143</fpage>–<lpage>155</lpage>.<pub-id pub-id-type="pmid">16540748</pub-id></mixed-citation>
</ref>
<ref id="bibr76-1179546817698134">
<label>76</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marks</surname><given-names>ML</given-names></name><name><surname>Whisler</surname><given-names>SL</given-names></name><name><surname>Clericuzio</surname><given-names>C</given-names></name><name><surname>Keating</surname><given-names>M.</given-names></name></person-group>
<article-title>A new form of long QT syndrome associated with syndactyly</article-title>. <source/>J Am Coll Cardiol. <year>1995</year>;<volume>25</volume>:<fpage>59</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">7798527</pub-id></mixed-citation>
</ref>
<ref id="bibr77-1179546817698134">
<label>77</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marks</surname><given-names>ML</given-names></name><name><surname>Trippel</surname><given-names>DL</given-names></name><name><surname>Keating</surname><given-names>MT.</given-names></name></person-group>
<article-title>Long QT syndrome associated with syndactyly identified in females</article-title>. <source/>Am J Cardiol. <year>1995</year>;<volume>76</volume>:<fpage>744</fpage>–<lpage>745</lpage>.<pub-id pub-id-type="pmid">7572644</pub-id></mixed-citation>
</ref>
<ref id="bibr78-1179546817698134">
<label>78</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guauque-Olarte</surname><given-names>S</given-names></name><name><surname>Messika-Zeitoun</surname><given-names>D</given-names></name><name><surname>Droit</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Calcium signaling pathway genes <italic>RUNX2</italic> and <italic>CACNA1C</italic> are associated with calcific aortic valve disease</article-title>. <source/>Circ Cardiovasc Genet. <year>2015</year>;<volume>8</volume>:<fpage>812</fpage>–<lpage>822</lpage>.<pub-id pub-id-type="pmid">26553695</pub-id></mixed-citation>
</ref>
<ref id="bibr79-1179546817698134">
<label>79</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Green</surname><given-names>EK</given-names></name><name><surname>Grozeva</surname><given-names>D</given-names></name><name><surname>Jones</surname><given-names>I</given-names></name><etal></etal></person-group>
<article-title>The bipolar disorder risk allele at <italic>CACNA1C</italic> also confers risk of recurrent major depression and of schizophrenia</article-title>. <source/>Molecular Psychiatry. <year>2010</year>;<volume>15</volume>:<fpage>1016</fpage>–<lpage>1022</lpage>.<pub-id pub-id-type="pmid">19621016</pub-id></mixed-citation>
</ref>
<ref id="bibr80-1179546817698134">
<label>80</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Benson</surname><given-names>DW</given-names></name><name><surname>Tristani-Firouzi</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Electrocardiographic features in Andersen-Tawil syndrome patients with <italic>KCNJ2</italic> mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype</article-title>. <source/>Circulation. <year>2005</year>;<volume>111</volume>:<fpage>2720</fpage>–<lpage>2726</lpage>.<pub-id pub-id-type="pmid">15911703</pub-id></mixed-citation>
</ref>
<ref id="bibr81-1179546817698134">
<label>81</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deo</surname><given-names>M</given-names></name><name><surname>Ruan</surname><given-names>Y</given-names></name><name><surname>Pandit</surname><given-names>SV</given-names></name><etal></etal></person-group>
<article-title>KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2013</year>;<volume>110</volume>:<fpage>4291</fpage>–<lpage>4296</lpage>.<pub-id pub-id-type="pmid">23440193</pub-id></mixed-citation>
</ref>
<ref id="bibr82-1179546817698134">
<label>82</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kalscheur</surname><given-names>MM</given-names></name><name><surname>Vaidyanathan</surname><given-names>R</given-names></name><name><surname>Orland</surname><given-names>KM</given-names></name><etal></etal></person-group>
<article-title><italic>KCNJ2</italic> mutation causes an adrenergic-dependent rectification abnormality with calcium sensitivity and ventricular arrhythmia</article-title>. <source/>Heart Rhythm. <year>2014</year>;<volume>11</volume>:<fpage>885</fpage>–<lpage>894</lpage>.<pub-id pub-id-type="pmid">24561538</pub-id></mixed-citation>
</ref>
<ref id="bibr83-1179546817698134">
<label>83</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>K</given-names></name><name><surname>Aiba</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with <italic>KCNJ2</italic> mutations</article-title>. <source/>Heart Rhythm. <year>2015</year>;<volume>12</volume>:<fpage>596</fpage>–<lpage>603</lpage>.<pub-id pub-id-type="pmid">25496985</pub-id></mixed-citation>
</ref>
<ref id="bibr84-1179546817698134">
<label>84</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ou</surname><given-names>Y</given-names></name><name><surname>Gibbons</surname><given-names>SJ</given-names></name><name><surname>Miller</surname><given-names>SM</given-names></name><etal></etal></person-group>
<article-title>SCN5A is expressed in human jejunal circular smooth muscle cells</article-title>. <source/>Neurogastroenterol Motil. <year>2002</year>;<volume>14</volume>:<fpage>477</fpage>–<lpage>486</lpage>.<pub-id pub-id-type="pmid">12358675</pub-id></mixed-citation>
</ref>
<ref id="bibr85-1179546817698134">
<label>85</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Strege</surname><given-names>PR</given-names></name><name><surname>Ou</surname><given-names>Y</given-names></name><name><surname>Sha</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Sodium current in human intestinal interstitial cells of Cajal</article-title>. <source/>Am J Physiol Gastrointest Liver Physiol. <year>2003</year>;<volume>285</volume>:<fpage>G1111</fpage>–<lpage>G1121</lpage>.<pub-id pub-id-type="pmid">12893628</pub-id></mixed-citation>
</ref>
<ref id="bibr86-1179546817698134">
<label>86</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saito</surname><given-names>YA</given-names></name><name><surname>Strege</surname><given-names>PR</given-names></name><name><surname>Tester</surname><given-names>DJ</given-names></name><etal></etal></person-group>
<article-title>Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy</article-title>. <source/>Am J Physiol Gastrointest Liver Physiol. <year>2009</year>;<volume>296</volume>:<fpage>G211</fpage>–<lpage>G218</lpage>.<pub-id pub-id-type="pmid">19056759</pub-id></mixed-citation>
</ref>
<ref id="bibr87-1179546817698134">
<label>87</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Verstraelen</surname><given-names>TE</given-names></name><name><surname>Ter Bekke</surname><given-names>RM</given-names></name><name><surname>Volders</surname><given-names>PG</given-names></name><name><surname>Masclee</surname><given-names>AA</given-names></name><name><surname>Kruimel</surname><given-names>JW.</given-names></name></person-group>
<article-title>The role of the <italic>SCN5A</italic>-encoded channelopathy in irritable bowel syndrome and other gastrointestinal disorders</article-title>. <source/>Neurogastroenterol Motil. <year>2015</year>;<volume>27</volume>:<fpage>906</fpage>–<lpage>913</lpage>.<pub-id pub-id-type="pmid">25898860</pub-id></mixed-citation>
</ref>
<ref id="bibr88-1179546817698134">
<label>88</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jung</surname><given-names>KT</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><etal></etal></person-group>
<article-title>The relationship between gastric myoelectric activity and <italic>SCN5A</italic> mutation suggesting sodium channelopathy in patients with Brugada syndrome and functional dyspepsia—a pilot study</article-title>. <source/>J Neurogastroenterol Motil. <year>2012</year>;<volume>18</volume>:<fpage>58</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">22323988</pub-id></mixed-citation>
</ref>
<ref id="bibr89-1179546817698134">
<label>89</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Llanos</surname><given-names>P</given-names></name><name><surname>Contreras-Ferrat</surname><given-names>A</given-names></name><name><surname>Barrientos</surname><given-names>G</given-names></name><name><surname>Valencia</surname><given-names>M</given-names></name><name><surname>Mears</surname><given-names>D</given-names></name><name><surname>Hidalgo</surname><given-names>C.</given-names></name></person-group>
<article-title>Glucose-dependent insulin secretion in pancreatic β-cell islets from male rats requires Ca<sup>2+</sup> release via ROS-stimulated ryanodine receptors</article-title>. <source/>PLoS ONE. <year>2015</year>;<volume>10</volume>:<fpage>e0129238</fpage>.<pub-id pub-id-type="pmid">26046640</pub-id></mixed-citation>
</ref>
<ref id="bibr90-1179546817698134">
<label>90</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Santulli</surname><given-names>G</given-names></name><name><surname>Pagano</surname><given-names>G</given-names></name><name><surname>Sardu</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Calcium release channel <italic>RYR2</italic> regulates insulin release and glucose homeostasis</article-title>. <source/>J Clin Invest. <year>2015</year>;<volume>125</volume>:<fpage>1968</fpage>–<lpage>1978</lpage>.<pub-id pub-id-type="pmid">25844899</pub-id></mixed-citation>
</ref>
<ref id="bibr91-1179546817698134">
<label>91</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heron</surname><given-names>SE</given-names></name><name><surname>Hernandez</surname><given-names>M</given-names></name><name><surname>Edwards</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Neonatal seizures and long QT syndrome: a cardiocerebral channelopathy?</article-title>
<source/>Epilepsia. <year>2010</year>;<volume>51</volume>:<fpage>293</fpage>–<lpage>296</lpage>.<pub-id pub-id-type="pmid">19863579</pub-id></mixed-citation>
</ref>
<ref id="bibr92-1179546817698134">
<label>92</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tiron</surname><given-names>C</given-names></name><name><surname>Campuzano</surname><given-names>O</given-names></name><name><surname>Perez-Serra</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Further evidence of the association between LQT syndrome and epilepsy in a family with <italic>KCNQ1</italic> pathogenic variant</article-title>. <source/>Seizure. <year>2015</year>;<volume>25</volume>:<fpage>65</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">25645639</pub-id></mixed-citation>
</ref>
<ref id="bibr93-1179546817698134">
<label>93</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JH</given-names></name><name><surname>Bos</surname><given-names>JM</given-names></name><name><surname>Cascino</surname><given-names>GD</given-names></name><name><surname>Ackerman</surname><given-names>MJ.</given-names></name></person-group>
<article-title>Prevalence and spectrum of electroencephalogram-identified epileptiform activity among patients with long QT syndrome</article-title>. <source/>Heart Rhythm. <year>2014</year>;<volume>11</volume>:<fpage>53</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">24103226</pub-id></mixed-citation>
</ref>
<ref id="bibr94-1179546817698134">
<label>94</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ryland</surname><given-names>KE</given-names></name><name><surname>Hawkins</surname><given-names>AG</given-names></name><name><surname>Weisenberger</surname><given-names>DJ</given-names></name><etal></etal></person-group>
<article-title>Promoter methylation analysis reveals that <italic>KCNA5</italic> ion channel silencing supports Ewing sarcoma cell proliferation</article-title>. <source/>Mol Cancer Res. <year>2016</year>;<volume>14</volume>:<fpage>26</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">26573141</pub-id></mixed-citation>
</ref>
<ref id="bibr95-1179546817698134">
<label>95</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kurokawa</surname><given-names>J.</given-names></name></person-group>
<article-title>Compartmentalized regulations of ion channels in the heart</article-title>. <source/>Biol Pharm Bull. <year>2007</year>;<volume>30</volume>:<fpage>2231</fpage>–<lpage>2237</lpage>.<pub-id pub-id-type="pmid">18057704</pub-id></mixed-citation>
</ref>
<ref id="bibr96-1179546817698134">
<label>96</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schulz</surname><given-names>DJ</given-names></name><name><surname>Temporal</surname><given-names>S</given-names></name><name><surname>Barry</surname><given-names>DM</given-names></name><name><surname>Garcia</surname><given-names>ML.</given-names></name></person-group>
<article-title>Mechanisms of voltage-gated ion channel regulation: from gene expression to localization</article-title>. <source/>Cell Mol Life Sci. <year>2008</year>;<volume>65</volume>:<fpage>2215</fpage>–<lpage>2231</lpage>.<pub-id pub-id-type="pmid">18408887</pub-id></mixed-citation>
</ref>
<ref id="bibr97-1179546817698134">
<label>97</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Terentyev</surname><given-names>D</given-names></name><name><surname>Rees</surname><given-names>CM</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><etal></etal></person-group>
<article-title>Hyperphosphorylation of RyRs underlies triggered activity in transgenic rabbit model of LQT2 syndrome</article-title>. <source/>Circ Res. <year>2014</year>;<volume>115</volume>:<fpage>919</fpage>–<lpage>928</lpage>.<pub-id pub-id-type="pmid">25249569</pub-id></mixed-citation>
</ref>
<ref id="bibr98-1179546817698134">
<label>98</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghouse</surname><given-names>J</given-names></name><name><surname>Have</surname><given-names>CT</given-names></name><name><surname>Weeke</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Rare genetic variants previously associated with congenital forms of long QT syndrome have little or no effect on the QT interval</article-title>. <source/>Eur Heart J. <year>2015</year>;<volume>36</volume>:<fpage>2523</fpage>–<lpage>2529</lpage>.<pub-id pub-id-type="pmid">26159999</pub-id></mixed-citation>
</ref>
<ref id="bibr99-1179546817698134">
<label>99</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ingles</surname><given-names>J</given-names></name><name><surname>Semsarian</surname><given-names>C.</given-names></name></person-group>
<article-title>Conveying a probabilistic genetic test result to families with an inherited heart disease</article-title>. <source/>Heart Rhythm. <year>2014</year>;<volume>11</volume>:<fpage>1073</fpage>–<lpage>1078</lpage>.<pub-id pub-id-type="pmid">24632221</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>